U.S. FDA warns against malaria drugs Trump championed for COVID-19

The U.S. Food and Drug Administration on Friday cautioned against the use of malaria drug hydroxychloroquine, touted by President Donald Trump, in COVID-19 patients outside of hospitals and clinical trials, citing risks of serious heart rhythm problems.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news